EPO and anemia (phenotype): The present study found that patients who received ESP treatment exhibited a statistically significant improvement in exercise capacity and confirmed a previous report, according to which subcutaneous EPO administration improves exercise capacity, quality of life and LVEF in patients with CHF and anemia (29).